Geng Chen

Geng Chen is a Partner at Susman Godfrey L.L.P. with a practice encompassing various forms of complex commercial litigation, including patent infringement and trade secret misappropriation. Her experience spans technology areas such as wearable fitness tracking devices, as evidenced by her representation of Jawbone in cases against Fitbit in the International Trade Commission (ITC). While her tracked patent litigation appearance, Personalized Media Communications, LLC v. Netflix, Inc., saw her act as Of Counsel for the plaintiff, her firm profile indicates she represents both plaintiffs and defendants across a broad range of disputes.

Chen's litigation experience includes significant outcomes beyond patent matters, such as securing a $266 million verdict for the City of Baltimore in an opioid lawsuit and helping obtain a settlement valued over $100 million on behalf of a class of songwriters and composers against Spotify USA Inc.. She also contributed to multiple settlements totaling $781 million in the In re: Libor-Based Financial Instruments Antitrust Litigation. There is no reliably sourced information indicating extensive experience in Patent Trial and Appeal Board (PTAB) or Inter Partes Review (IPR) proceedings.

Prior to joining Susman Godfrey, Chen served as a law clerk to the Honorable Jacques L. Wiener Jr. of the United States Court of Appeals for the Fifth Circuit.

She earned her J.D., magna cum laude, from Harvard Law School, where she was an Executive Editor of the Harvard Law Review. Chen also holds a B.S. in Chemical Engineering, summa cum laude, from Rice University. She is admitted to the New York Bar.